Modern methods of diagnostics of myocard function

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The present article is devoted to the modern methods of the identification of the viable myocardium. The pathogenesis of the hibernating myocardium and the stunned myocardium is described. The article reviews possibilities and limitations of stress echocardiography, single-photon emission tomography, positron emission tomography.

About the authors

V. S. Nikiforov

Medical Military Academy

Author for correspondence.
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

A. E. Nikitin

Medical Military Academy

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

A. E. Filippov

Medical Military Academy

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

K. A. Soloduhin

Medical Military Academy

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

A. S. Svistov

Medical Military Academy

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

References

  1. Аронов Д. М., Лупанов В. П. Функциональные пробы в кардиологии. М.: МЕД-пресс-информ, 2002. 296 с.
  2. Аляви А. Л., Зуфаров М. М., Туляганова Д. К. Обратимые дисфункции жизнеспособного миокарда у больных ишемической болезнью сердца // Клин. мед. 2002. Т. 80 (8). С. 18–22.
  3. Горнякова Н. Б., Ботвин И. М., Сумароков А. Б. и др. Оценка жизнеспособности миокарда методом стресс-эхокардиографии с добутамином у больных ишемической болезнью сердца // Кардиология. 2004. Т. 44 (7). C. 29-34.
  4. Седов В. П., Алехин М. Н., Корнеев Н. В. Стресс-эхокардиография. М.: ЗАО «Информатик», 2000. 152 с.
  5. Шумаков В. И., Остроумов Е. Н. Радионуклидные методы диагностики в клинике ишемической болезни и трансплантации сердца. М.: Дрофа, 2003. 224 с.
  6. Afridi I., Grayburn P. A., Panza J. et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 921-926.
  7. Aktas A., Caner B. Immediate thallium re-injection after stress imaging for the detection of myocardial viability // Nucl. Med. Commun. 2000. Vol. 21. № 2. Р. 143–146.
  8. Ambrosio G., Tritto I. Clinical manifestations of myocardial stunning // Coron. Artery Dis. 2001. Vol. 12. № 5. Р. 357-361.
  9. Barrington S. F., Chambers J., Hallett W. A. et al. Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium // Eur. J. Nucl. Med. Mol. Imaging. 2004. Vol. 31. № 3. Р. 355-361.
  10. Beanlands R. S., Ruddy T. D., deKemp R. A. et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function // J. Am. Coll. Cardiol. 2002. Vol. 40. № 10. Р. 1735-1743.
  11. Bello D., Shah D. J., Farah G. M. et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing betablocker therapy // Circulation. 2003. Vol. 108. № 16. Р. 1945–1953.
  12. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning // Physiol. Rev. 1999. Vol. 79. P. 609-612.
  13. Bountioukos M., Schinkel A. F., Bax J. J. et al. Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy // Am. Heart J. 2004. Vol. 148. № 6. Р. 1079–1084.
  14. Brown T. A. Hibernating myocardium // Am. J. Crit. Care. 2001. Vol. 10. № 2. Р. 84–91.
  15. Canty J. M., Fallavollita J. A. Chronic hibernation and chronic stunning: a continuum // J. Nucl. Cardiol. 2000. Vol. 7. № 5. Р. 509-527.
  16. Duncan B. H., Ahlberg A. W., Levine M. G. et al. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability // Am. J. Cardiol. 2000. Vol. 85. № 6. Р. 680-684.
  17. Everaert H., Vanhove C., Franken P. R. Lowdose dobutamine gated single-photon emission tomography: comparison with stress echocardiography // Eur. J. Nucl. Med. 2000. Vol. 27. № 4. Р. 413-418.
  18. Fallavollita J. A., Lim H., Canty J. М. Муосyte apoptosis and reduced SR gene expression precede the transition from chronically stunned to hibernating myocardium // J. Mol. Cell. Cardiol. 2001. Vol. 33. № 11. Р. 1937–1944.
  19. Galatro K., Chaudhry F. A. Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy // Echocardiography. 2000. Vol. 17. №1. Р. 61–67.
  20. Ghesani M., Depuey E. G., Rozanski A. Role of F-18 FDG Positron Emission Tomography (PEТ) in the Assessment of Myocardial Viability // Echocardiography. 2005. Vol. 22. № 2. Р. 165–177.
  21. Gowda R. M., Khan I. A., Vasavada B. C. et al. Reversible myocardial dysfunction: basics and evaluation // Int. J. Cardiol. 2004. Vol. 97. № 3. P. 349-353.
  22. Gropler R. J., Soto P. Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient // Curr. Cardiol. Rep. 2004. Vol. 6. №1. P. 20-26.
  23. Gunning M. G., Kaprielian R. R., Pepper J. et al. The histology of viable and hibernating myocardium in relation to imaging characteristics // J. Am. Coll. Cardiol. 2002. Vol. 39. № 3. P. 428-435.
  24. He W., Acampa W., Mainolfi C. et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET // J. Nucl. Cardiol. 2003. Vol. 10. № 6. Р. 599–606.
  25. Heusch G. Hibernating myocardium // Physiol. Rev. 1998. Vol. 78. P. 1055-1085.
  26. Hoffmann R., Altiok E., Nowak B. et al. Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function // J. Am. Coll. Cardiol. 2002. Vol. 39. № 3. Р. 443-449.
  27. Isobe S., Ando A., Nanasato M. et al. Combined study with FDG PET and TI SPECT in patients with idiopathic dilated cardiomyopathy // Nucl. Med. Commun. 2003. Vol. 24. № 10. P. 1071-1080.
  28. Kayano H., Ozawa M., Koh S. et al. Significance of low-dose dobutamine stress echocardiography for the prediction of the long-term prognosis for patients with acute myocardial infarction // J. Cardiol. 2003. Vol. 41. № 3. Р. 109-117.
  29. Klocke F. J., Simonetti O.P., Judd R. M. et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by firstpass magnetic resonance perfusion imaging // Circulation. 2001. Vol. 104. № 20. Р. 2412-2416.
  30. Kloner R. A., Jennings R. B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part I // Circulation. 2001. Vol. 104. P. 2981-2989.
  31. Leoncini M., Marcucci G., Sciagra R. et al. Comparison of baseline and low-dose dobutamine technetium-99m sestamibi scintigraphy with low-dose dobutamine echocardiography for predicting functional recovery after revascularization // Am. J. Cardiol. 2000. Vol. 86. № 2. P. 153-157.
  32. Leoncini M., Sciagra R. Role of perfusion myocardial scintigraphy with gated SPECT technique in the diagnostic and prognostic evaluation of patients with chronic coronary disease // Ital. Heart J. Suppl. 2002. Vol. 3. № 3. Р. 309–318.
  33. Lloyd S. G., Gupta H. Assessment of myocardial viability by cardiovascular magnetic resonance // Echocardiography. 2005. Vol. 22. № 2. P. 179-193.
  34. Mari C., Strauss W. H. Detection and characterization of hibernating myocardium // Nucl. Med. Commun. 2002. Vol. 23. № 4. Р. 311-322.
  35. Mazzadi A. N., Janier M. F., Brossier B. et al. Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: relationship with PEТ findings // Am. J. Physiol. Heart Circ. Physiol. 2004. Vol. 286. № 5. P. H1946-1953.
  36. McMurray J. J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure // Heart. 2000. Vol. 83. Р. 596-602.
  37. Mehta D., Iskandrian A. E. Myocardial viability: nuclear assessment // Echocardiography. 2005. Vol. 22. № 2. Р. 155-164.
  38. Minamihaba O., Takeishi Y., Hirono O. et al. Pulsed Doppler tissue imaging for the assessment of myocardial viability: comparison with 99mTc sestamibi perfusion imaging // Nucl. Med. Commun. 2002. Vol. 23. № 12. Р. 1197-1204.
  39. Moreno J. B., Beltran A., Pouso J. et al. Clinical utility of low dose dobutamine echocardiography in regional myocardial viability detection before and after surgical revascularization // Echocardiography. 2002. Vol. 19. Pt. 1. P. 537-547.
  40. Nakano A., Yonekura Y., Lee J. D. et al. Reversible defect of 1231-15-(p-iodophenyl)-9-(R,S)- methylpentadecanoic acid indicates residual viability within infarct-related area // Ann. Nucl. Med. 2002. Vol. 16. № 3. Р. 183-187.
  41. Pirich C., Schwaiger M. The clinical role of positron emission tomography in management of the cardiac patient // Rev. Port. Cardiol. 2000. Vol. 19. Suppl. 1. P. 100-189.
  42. Previtali M. Myocardial viability in ischemic heart disease: new directions and perspectives // Ital. Heart J. 2001. Vol. 2. № 2. Р. 93–99.
  43. Rahimtoola S. H. Concept and evaluation of hibernating myocardium // Annu. Rev. Med. 1999. Vol. 50. P. 75-86.
  44. Rambaldi R., Poldermans D., Bax J. J. et al. Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction // Eur. Heart J. 2000. Vol. 21. № 13. P. 1091-1098.
  45. Redwood S. R., Ferrari R., Marber M. S. Myocardial hibernation and stunning: from physiological principles to clinical practice // Heart. 1998. Vol. 80. Р. 218-222.
  46. Schinkel A. F., Bax J. J., Sozzi F. B. et al. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction // Heart. 2002. Vol. 88. № 2. P. 125-130.
  47. Schulz R., Heusch G. Hibernating myocardium // Heart. 2000. Vol. 84. № 6. Р. 587-594.
  48. Scognamiglio R., Negut C., Palisi M. Spontaneous recovery of myocardial asynergic segments following acute myocardial infarction. The role of post-extrasystolic potentiation echocardiography in the predischarge evaluation // Eur. J. Echocardiogr. 2003. Vol. 4. № 2. Р. 135-140.
  49. Segall G. Assessment of myocardial viability by positron emission tomography // Nucl. Med. Commun. 2002. Vol. 23. № 4. Р. 323-330.
  50. Senior R., Kaul S., Raval U. et al. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy // J. Nucl. Cardiol. 2002. Vol. 9. № 5. Р. 454-462.
  51. Senior R., Lahiri A. Role of dobutamine echocardiography in detection of myocardial viability for predicting outcome after revascularization in ischemic cardiomyopathy // J. Am. Soc. Echocardiogr. 2001. Vol. 14. № 3. Р. 240-248.
  52. Shimoni S., Frangogiannis N. G., Aggeli C. J. et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy // Circulation. 2003. Vol. 107 № 4. Р. 538-544.
  53. Soman P., Udelson J. E. Prognostic and therapeutic implications of myocardial viability in patients with heart failure // Curr. Cardiol. Rep. 2004. Vol. 6. № 3. Р. 211-216.
  54. Swinburn J. M., Lahiri A., Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dyssynergic myocardium early after acute myocardial infarction // J. Am. Coll. Cardiol. 2001. Vol. 38. № 1. Р. 19-25.
  55. Tadamura E., Mamede M., Kubo S. et al. The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT // J. Nucl. Med. 2003. Vol. 44. № 5. Р. 745-751.
  56. Travin M. I., Bergmann S. R. Assessment of myocardial viability // Semin. Nucl. Med. 2005. Vol. 35. №1. Р. 2–16.
  57. Underwood S. R., Bax J. J., Dahl J. et al. Imaging techniques for the assessment of myocardial hibernation // Eur. Heart J. 2004. Vol. 25. № 10. P. 815-836.
  58. Verani M. S., Taillefer R., Iskandrian A. E. et al. 1231-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 1231-iodophenylpentadecanoic acid // J. Nucl. Med. 2000. Vol. 41. № 8. P. 1299–1307.
  59. Wagner A., Mahrholdt H., Kim R. J. et al. Use of cardiac magnetic resonance to assess viability // Curr. Cardiol. Rep. 2005. Vol. 7. № 1. P. 59-64.
  60. Wei K. Assessment of myocardial viability using myocardial contrast echocardiography // Echocardiography. 2005. Vol. 22. № 1. Р. 85-94.
  61. Yang J., Hu Z., Li C., Gao S. Value of low dose dobutamine Doppler tissue imaging for detecting hibernating myocardium // J. Tongji Med. Univ. 1999. Vol. 19. № 1. Р. 42-45.
  62. Yang H. S., Kang S. J., Song J. K. et al. Diagnosis of viable myocardium using velocity data of Doppler myocardial imaging: comparison with positron emission tomography // J. Am. Soc. Echocardiography. 2004. Vol. 17. № 9. P. 933-940.
  63. Yamagishi H., Akioka K., Hirata K. et al. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium // J. Nucl. Cardiol. 2001. Vol. 8. № 1. P. 58-67.
  64. Yao S. S., Chaudhry F. A. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction // Echocardiography. 2005. Vol. 22. № 1. Р. 71–83.
  65. Yoshinaga K., Katoh C., Noriyasu K. et al. Lowdose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET // Eur. J. Nucl. Med. Mol. Imaging. 2002. Vol. 29. № 7. Р. 882-890.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2005 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.